A Novel Treatment of Premature Ejaculation François Giuliano  European Urology Supplements  Volume 6, Issue 13, Pages 780-786 (July 2007) DOI: 10.1016/j.eursup.2007.04.005 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Plasma concentrations of dapoxetine 30mg and 60mg over time. Data adapted from Andersson et al [13]. European Urology Supplements 2007 6, 780-786DOI: (10.1016/j.eursup.2007.04.005) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Plasma concentrations over time for dapoxetine 60mg (A), paroxetine 40mg (B), sertraline 100mg (C), and fluoxetine 20mg (D). Data adapted from Andersson et al [13]. European Urology Supplements 2007 6, 780-786DOI: (10.1016/j.eursup.2007.04.005) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 3 Distribution of IELT among men with PE (n=198) and men without PE (n=1355) with a mean of 3.00 (range: 0–41) and 9.2 (range: 0–53), respectively. IELT=intravaginal ejaculatory latency time; PE=premature ejaculation. Data adapted from Patrick et al [26]. European Urology Supplements 2007 6, 780-786DOI: (10.1016/j.eursup.2007.04.005) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 4 Improvement in self-reported control over ejaculation in men taking dapoxetine 30mg or 60mg versus placebo. *p<0.0001 vs. placebo. Data adapted from Pryor et al [27]. European Urology Supplements 2007 6, 780-786DOI: (10.1016/j.eursup.2007.04.005) Copyright © 2007 European Association of Urology Terms and Conditions